Page last updated: 2024-10-16

carbamates and Diabetic Nephropathies

carbamates has been researched along with Diabetic Nephropathies in 8 studies

Diabetic Nephropathies: KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE.

Research Excerpts

ExcerptRelevanceReference
"Repaglinide has a good safety and efficacy profile in type 2 diabetic patients complicated by renal impairment and is an appropriate treatment choice, even for individuals with more severe degrees of renal impairment."2.71Safety and efficacy of repaglinide in type 2 diabetic patients with and without impaired renal function. ( Hasslacher, C, 2003)
"Diet or tablet-treated patients with Type 2 diabetes (n = 256; age 40-75 years, body mass index (BMI) 20-35 kg/m2, HbA1c 4."2.70Comparison between repaglinide and glipizide in Type 2 diabetes mellitus: a 1-year multicentre study. ( Dejgaard, A; Kilhovd, B; Lager, I; Madsbad, S; Mustajoki, P, 2001)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19903 (37.50)18.7374
1990's0 (0.00)18.2507
2000's3 (37.50)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Delanghe, S1
Moerman, A1
Pletinck, A1
Schepers, E1
Glorieux, G1
Van Biesen, W1
Delanghe, JR1
Speeckaert, MM1
del Pozo-Fernández, C1
Pardo-Ruiz, C1
Sánchez-Botella, C1
Blanes-Castañer, V1
López-Menchero, R1
Gisbert-Sellés, C1
Sánchez-Jodar, C1
Alvarez-Avellán, L1
Hasslacher, C1
Kraus, LM1
Kraus, AP1
Madsbad, S1
Kilhovd, B1
Lager, I1
Mustajoki, P1
Dejgaard, A1
Camerini-Davalos, RA3
Reddi, AS3
Ehrenreich, TH1
Strugatz, LH1
Oppermann, W3
Chen, M1
Velasco, CA1

Reviews

1 review available for carbamates and Diabetic Nephropathies

ArticleYear
Carbamoylation of amino acids and proteins in uremia.
    Kidney international. Supplement, 2001, Volume: 78

    Topics: Amino Acids; Animals; Carbamates; Cyanates; Diabetic Nephropathies; Enzymes; Glucose; Hormones; Huma

2001

Trials

2 trials available for carbamates and Diabetic Nephropathies

ArticleYear
Safety and efficacy of repaglinide in type 2 diabetic patients with and without impaired renal function.
    Diabetes care, 2003, Volume: 26, Issue:3

    Topics: Aged; Blood Glucose; Carbamates; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans;

2003
Comparison between repaglinide and glipizide in Type 2 diabetes mellitus: a 1-year multicentre study.
    Diabetic medicine : a journal of the British Diabetic Association, 2001, Volume: 18, Issue:5

    Topics: Adult; Aged; Blood Glucose; C-Peptide; Carbamates; Diabetes Mellitus, Type 2; Diabetic Nephropathies

2001

Other Studies

5 other studies available for carbamates and Diabetic Nephropathies

ArticleYear
Quantification of carbamylated albumin in serum based on capillary electrophoresis.
    Electrophoresis, 2017, Volume: 38, Issue:17

    Topics: Adult; Aged; Carbamates; Diabetic Nephropathies; Electrophoresis, Capillary; Female; Humans; Male; M

2017
Discrepancies among consensus documents, guidelines, clinical practice and the legal framework for the treatment of type 2 diabetes mellitus patients.
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2012, May-14, Volume: 32, Issue:3

    Topics: Acidosis, Lactic; Aged; Carbamates; Consensus Development Conferences as Topic; Contraindications; D

2012
Diabetic glomerulosclerosis in KK mice and its prevention by glyburide and pyridinolcarbamate.
    Advances in experimental medicine and biology, 1979, Volume: 119

    Topics: Animals; Blood Glucose; Carbamates; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glucose

1979
Diabetic microangiopathy in KK mice. IV. Effect of pyridinolcarbamate on kidney glucosyltransferase activity and glomerulosclerosis.
    Experimental and molecular pathology, 1978, Volume: 29, Issue:2

    Topics: Animals; Carbamates; Diabetic Nephropathies; Glucosyltransferases; Kidney; Kidney Cortex; Mice; Pyri

1978
Diabetic microangiopathy in KK mice. II. Suppression of Glomerulosclerosis by pyridinolcarbamate.
    Experimental and molecular pathology, 1977, Volume: 26, Issue:2

    Topics: Animals; Body Weight; Carbamates; Diabetic Nephropathies; Drug Evaluation, Preclinical; Glucose; Glu

1977